Formerly Bridge Biotherapeutics, Parataxis Korea became South Korea's first institutionally-backed public Bitcoin treasury company in August 2025 after Parataxis Holdings acquired a controlling stake. The company accumulates BTC through equity financing rounds and plans to integrate Bitcoin mining operations.
| Instrument | Term | Coupon | Principal | Outstanding | Conv. price | BTC Rating |
|---|---|---|---|---|---|---|
| 288330-CB1 | Jul '25 – Jul '28 | 0% | 5.00B KRW | 5.00B KRW | 789.00 KRW | 1.4x |
| Total | 5.00B KRW | |||||
206 BTC pledged as USDT loan collateral. Q1 acquisitions: 19.95 BTC OTC + 6.43 BTC mining; 3.0096 BTC disposed via sales / network fees.
Quarterly Report (분기보고서) — period ending 2026.03.31155 BTC pledged as collateral for KestrelX USDT loan
Annual Report 2025 (사업보고서)Common shares only (preferred net 1,862 excluded; treasury 3,294)
Annual Report 2025 (사업보고서)Face USD-equivalent at year-end; FVTPL carrying value KRW 14,932,993,322
Annual Report 2025 (사업보고서)